Kazuyoshi Saito Selected Research

Kazuyoshi Saito Research Topics

Disease

71	Rheumatoid Arthritis 01/2022 - 05/2003
20	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 10/2003
16	Neoplasms (Cancer) 01/2022 - 01/2002
8	Inflammation (Inflammations) 01/2019 - 12/2006
7	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2002
7	Rheumatic Diseases (Rheumatism) 01/2020 - 01/2007
7	Carcinoma (Carcinomatosis) 01/2006 - 07/2002
6	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 07/2022 - 12/2007
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2002
6	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2020 - 03/2009
6	Infections 08/2012 - 02/2004
5	Vasculitis (Vasculitides) 01/2022 - 12/2003
5	Neoplasm Metastasis (Metastasis) 10/2005 - 04/2002
4	Fever (Fevers) 01/2022 - 06/2009
4	Immunoglobulin G4-Related Disease 01/2022 - 12/2012
4	Arthritis (Polyarthritis) 01/2021 - 02/2004
4	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2020 - 06/2002
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 01/2021
3	Pneumonia (Pneumonitis) 01/2022 - 03/2009
3	Heart Failure 12/2014 - 11/2009
3	Lung Diseases (Lung Disease) 02/2014 - 11/2012
3	Opportunistic Infections (Opportunistic Infection) 11/2012 - 01/2005
3	Synovitis 06/2012 - 05/2003
2	Mixed Connective Tissue Disease (MCTD) 11/2022 - 01/2005
2	Pulmonary Arterial Hypertension 11/2022 - 12/2020
2	Spontaneous Remission 01/2022 - 01/2022
2	Disease Progression 01/2022 - 04/2011
2	Microscopic Polyangiitis 01/2022 - 01/2021
2	Exanthema (Rash) 01/2022 - 01/2019
2	Fibrosis (Cirrhosis) 01/2022 - 10/2009
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2021 - 11/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2020
2	Adenoma (Adenomas) 01/2020 - 02/2004
2	Behcet Syndrome (Behcet's Syndrome) 01/2019 - 08/2009
2	Lupus Nephritis 01/2017 - 01/2017
2	Bone Fractures (Bone Fracture) 11/2016 - 11/2008
2	Bone Resorption 11/2016 - 08/2004
2	Osteoporosis 11/2016 - 01/2012
2	Pathologic Processes 11/2016 - 11/2013
2	Dermatomyositis (Dermatopolymyositis) 01/2012 - 01/2008
2	Drug-Related Side Effects and Adverse Reactions 10/2011 - 01/2007
2	Atrophy 05/2011 - 10/2009
2	Body Weight (Weight, Body) 04/2011 - 08/2002
2	Sjogren's Syndrome (Sjogren Syndrome) 10/2009 - 12/2003

Drug/Important Bio-Agent (IBA)

16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2008
14	Infliximab (Remicade)FDA Link 12/2017 - 01/2007
13	tocilizumab (atlizumab)FDA Link 01/2021 - 01/2009
12	Biological ProductsIBA 01/2018 - 02/2004
11	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2007
10	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 08/2002
10	Etanercept (Enbrel)FDA Link 09/2016 - 01/2009
9	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 07/2011
9	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2018 - 12/2004
8	GlucocorticoidsIBA 01/2022 - 01/2004
8	Abatacept (Orencia)FDA Link 01/2018 - 01/2014
7	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 02/2004
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2003
6	Pharmaceutical PreparationsIBA 01/2020 - 01/2007
6	CytokinesIBA 01/2020 - 08/2002
6	Monoclonal AntibodiesIBA 01/2020 - 01/2008
5	Adalimumab (Humira)FDA Link 09/2020 - 06/2012
5	Antirheumatic Agents (DMARD)IBA 01/2019 - 02/2004
5	Biomarkers (Surrogate Marker)IBA 11/2016 - 01/2009
4	SteroidsIBA 07/2022 - 10/2003
4	Rituximab (Mabthera)FDA Link 01/2022 - 01/2007
4	Fluorouracil (Carac)FDA LinkGeneric 03/2003 - 11/2002
3	InterferonsIBA 01/2020 - 06/2012
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 03/2011
3	AutoantibodiesIBA 01/2019 - 01/2009
3	alfacalcidolIBA 11/2016 - 01/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 01/2009
3	Etidronic Acid (HEDP)FDA LinkGeneric 01/2012 - 01/2004
2	AntibodiesIBA 11/2022 - 01/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 05/2022 - 11/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 08/2018
2	Certolizumab Pegol FDA Link 01/2021 - 01/2021
2	Thymidine Monophosphate (TMP)IBA 01/2020 - 01/2017
2	Trimethoprim (Proloprim)FDA LinkGeneric 01/2020 - 01/2017
2	Sulfamethoxazole FDA LinkGeneric 01/2020 - 01/2017
2	CT-P13IBA 03/2017 - 01/2015
2	Diphosphonates (Bisphosphonates)IBA 11/2016 - 11/2008
2	3-benzoyl dopamine (MBDA)IBA 11/2016 - 05/2015
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 11/2016 - 11/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 06/2009
2	Proteins (Proteins, Gene)FDA Link 12/2014 - 12/2007
2	tofacitinibIBA 05/2014 - 06/2012
2	Syk KinaseIBA 01/2012 - 06/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2011 - 03/2010
2	Dopamine (Intropin)FDA LinkGeneric 03/2011 - 02/2009
2	Adenosine Triphosphate (ATP)IBA 04/2010 - 12/2002
2	Tacrolimus (Prograf)FDA LinkGeneric 03/2010 - 04/2007

Therapy/Procedure

37	Therapeutics 01/2022 - 11/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
4	Laparotomy 07/2006 - 01/2003
4	Pancreaticoduodenectomy 01/2006 - 08/2002
4	Intravenous Infusions 03/2003 - 06/2002
3	Lymph Node Excision (Lymph Node Dissection) 01/2006 - 07/2002
2	Remission Induction 01/2022 - 12/2017
2	Traction 05/2016 - 02/2003
2	Biological Therapy 02/2014 - 11/2012